Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips This article is excerpted from Tom Yeung’s Profit & Protection newsletter dated July 28, 2022. To make sure you don’t miss any of Tom’s picks, subscribe to his mailing list here . Sourc...
San Diego, California-based biotech Sorrento Therapeutics ( NASDAQ: SRNE ) traded higher on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) greenlighted an early-stage clinical trial for its oral COVID-19 therapy STI-1558. The FDA has s...
STI-1558, an oral SARS-CoV-2 main protease inhibitor which can block viral replication, is specifically designed as a standalone treatment of COVID-19. Studies to date indicate that STI-1558 does not require the co-administration of ritonavir as a booster for CYP3A4 inhibition. ST...
Sorrento's outsized ambitions are not playing well for shareholders. Sorrento has assembled a significant group of COVID-19 assets that could perk up its value as the pandemic smolders ever hotter. Sorrento's performance has not lived up to its potential. Sorrento ( SR...
The back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading session in the volatile healthcare sector is a case in point. For example, shares of the clinical-stage biotech Ocugen (NASDAQ: OCGN) were down by a hefty 9.5% and Sorrento Therape...
Scilex Holding Co., a subsidiary of Sorrento Therapeutics ( NASDAQ: SRNE ), is acquiring privately held medtech Ancora Medical . Ancora's key asset is its Nerve Block Catheter Set for surgical pain management during the pre-operative, perioperative and post-opera...
Ancora Medical Inc. (“Ancora”) is a privately held medical technology company with an FDA approved product in February 2020, the Nerve Block Catheter Set which is indicated for surgical pain management during the pre-operative, perioperative and post-operative periods associ...
3 Hot Penny Stocks to Watch During Trading This Week With another dismal start to a week for penny stocks and blue chips, there is a lot for investors to know right now. Although trading penny stocks has not been easy lately, there have been some opportunities for investors to profi...
PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a commercial biopharmaceutical company focused on developing...
Penny stocks continue lighting up the boards as retail traders take a breather from investing and focus on day trading. Whether it’s the latest short squeeze stock or meme stocks to watch, daily trends are plentiful when it comes to capitalizing on short-term moves in the stock marke...
News, Short Squeeze, Breakout and More Instantly...
Sorrento Therapeutics Inc. Company Name:
SRNE Stock Symbol:
NASDAQ Market:
Sorrento Therapeutics Inc. Website:
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...